These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 4336757)
1. [Drug-induced pathomorphosis of skin lesions in leprosy]. VishnevetskiÄ FE Arkh Patol; 1971; 33(9):70-7. PubMed ID: 4336757 [No Abstract] [Full Text] [Related]
2. [Immunologic and histomorphologic features of responsiveness in patients with leprosy at different stages of treatment]. Strukov AI; Babaiants RS; ShakhtmeÄster IIa; Kopieva TN; Goloschapov NM Vestn Dermatol Venerol; 1972 Oct; 46(10):8-12. PubMed ID: 4569353 [No Abstract] [Full Text] [Related]
4. Histochemical investigation of the activity of oxidoreductases in the skin lesions of lepromatous leprosy patients. Zuravleva GF Bull World Health Organ; 1972; 46(6):813-9. PubMed ID: 4342274 [TBL] [Abstract][Full Text] [Related]
5. The histoid leproma. Its characteristics and significance. Rodriguez JN Int J Lepr Other Mycobact Dis; 1969; 37(1):1-21. PubMed ID: 5817631 [No Abstract] [Full Text] [Related]
6. Follow up study of thirty-six borderline cases of leprosy. Kundu S; Ghosh S Bull Calcutta Sch Trop Med; 1967 Jul; 15(3):103-4. PubMed ID: 5616299 [No Abstract] [Full Text] [Related]
7. Lepromatous leprosy in reaction. A study of the liver and skin lesions. Kramarsky B; Edmondson HA; Peters RL; Reynolds TB Arch Pathol; 1968 May; 85(5):516-31. PubMed ID: 4870408 [No Abstract] [Full Text] [Related]
8. [Skin metabolism disorders in psoriasis in children. Histochemical and electron microscopic studies]. Stoudnitzine AA; Tzvetkova GM Ann Dermatol Syphiligr (Paris); 1972; 99(1):41-6. PubMed ID: 4340821 [No Abstract] [Full Text] [Related]
9. [Phagocytotic insufficiency and mitochondria changes in the leprosy cell]. Orfanos C Hautarzt; 1966 Oct; 17(10):459-63. PubMed ID: 5997578 [No Abstract] [Full Text] [Related]
10. Clinical stages in sulfone treatment of leprosy. Rodriguez JN Int J Lepr Other Mycobact Dis; 1970; 38(2):199-203. PubMed ID: 4920411 [No Abstract] [Full Text] [Related]
13. Pathobiologic significance of the subcellular organelles of lepra cells. Aquino TI; Skinsnes OK Int J Lepr Other Mycobact Dis; 1970; 38(2):134-48. PubMed ID: 5529245 [No Abstract] [Full Text] [Related]
14. Pathology--the doorway to the understanding of leprosy. Ward Burdick Award Address. Binford CH Am J Clin Pathol; 1969 Jun; 51(6):681-98. PubMed ID: 4890371 [No Abstract] [Full Text] [Related]
15. Skin of leprosy patients before and after treatment: electron microscopic study. Chirachariyavej T; Van Dellen A J Med Assoc Thai; 1982 Aug; 65(8):426-31. PubMed ID: 7142866 [No Abstract] [Full Text] [Related]
16. The treatment of leprosy with the sulfones. I. Faget's original 22 patients. A thirty-year follow-up on sulfone therapy for leprosy. Jacobson RR; Trautman JR Int J Lepr Other Mycobact Dis; 1971; 39(3):726-37. PubMed ID: 4948221 [No Abstract] [Full Text] [Related]
17. The antileprotic action of clofazimine (B663, G30, 320, Lamprene). Azulay RD; da Silva NC; Zeo A; Portela AB; Franca JC; Peluso LL Int J Lepr Other Mycobact Dis; 1974; 42(1):13-8. PubMed ID: 4607163 [No Abstract] [Full Text] [Related]
18. Leprosy and Australia. Boughton CR Med J Aust; 1972 Oct; 2(15):837-42. PubMed ID: 4644391 [No Abstract] [Full Text] [Related]
19. Biochemical and ultrastructural study of the relationship between lysosomal enzyme activities and chemotherapy. Kanetsuna F; Imaeda T Int J Lepr Other Mycobact Dis; 1968; 36(4):417-26. PubMed ID: 5753811 [No Abstract] [Full Text] [Related]
20. [Treatment of leprosy by sulfones and delayed-action sulfonamides: comparison of therapeutic results in 100 cases]. Privat Y; Faye I; Bellossi A Mars Med; 1968; 105(3):276-80. PubMed ID: 5754252 [No Abstract] [Full Text] [Related] [Next] [New Search]